Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Molecular Cancer Research : MCR|August 18, 2020
Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in <i>CRLF2</i>-Rearranged Ph-like ALLKeith C S Sia, Ling Zhong, Chelsea Mayoh, et al.
Cancer Letters|February 24, 2016
High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patientsPatrick Y Kim, Owen Tan, Bing Liu, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Regions syntenic to human 17q are gained in mouse and rat neuroblastomaMaria Łastowska, Yeun-Jun Chung, Ngan Cheng Ching, et al.
Cancer Research|November 3, 2007
p53 determines multidrug sensitivity of childhood neuroblastomaChengyuan Xue, Michelle Haber, Claudia Flemming, et al.
The FEBS Journal|January 26, 2022
GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulatorsKimberley M Hanssen, Madeleine S Wheatley, Denise M T Yu, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Mechanism of relapse in pediatric acute lymphoblastic leukemiaMichelle J Henderson, Seoyeon Choi, Alex H Beesley, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|February 7, 2018
MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastomaFrancesca Ferrucci, Roberto Ciaccio, Sara Monticelli, et al.
Cancer|December 17, 2016
Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working GroupSusan A Burchill, Klaus Beiske, Hiroyuki Shimada, et al.
Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.
Blood|May 16, 2002
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseRichard B Lock, Natalia Liem, Monica L Farnsworth, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Molecular Cancer Research : MCR|August 18, 2020
Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in <i>CRLF2</i>-Rearranged Ph-like ALLKeith C S Sia, Ling Zhong, Chelsea Mayoh, et al.
Cancer Letters|February 24, 2016
High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patientsPatrick Y Kim, Owen Tan, Bing Liu, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Regions syntenic to human 17q are gained in mouse and rat neuroblastomaMaria Łastowska, Yeun-Jun Chung, Ngan Cheng Ching, et al.
Cancer Research|November 3, 2007
p53 determines multidrug sensitivity of childhood neuroblastomaChengyuan Xue, Michelle Haber, Claudia Flemming, et al.
The FEBS Journal|January 26, 2022
GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulatorsKimberley M Hanssen, Madeleine S Wheatley, Denise M T Yu, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Mechanism of relapse in pediatric acute lymphoblastic leukemiaMichelle J Henderson, Seoyeon Choi, Alex H Beesley, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|February 7, 2018
MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastomaFrancesca Ferrucci, Roberto Ciaccio, Sara Monticelli, et al.
Cancer|December 17, 2016
Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working GroupSusan A Burchill, Klaus Beiske, Hiroyuki Shimada, et al.
Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.
Blood|May 16, 2002
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseRichard B Lock, Natalia Liem, Monica L Farnsworth, et al.
Pageof 19